Literature DB >> 19885226

Spending for diabetes drugs is increasing in the United States.

David C Klonoff.   

Abstract

Entities:  

Keywords:  Medco; cost; diabetes; drugs; generic; medications; spending

Year:  2008        PMID： 19885226      PMCID： PMC2769766          DOI： 10.1177/193229680800200401

Source DB:  PubMed          Journal:  J Diabetes Sci Technol        ISSN： 1932-2968


× No keyword cloud information.
  9 in total

1.  Investigation of racemisation of the enantiomers of glitazone drug compounds at different pH using chiral HPLC and chiral CE.

Authors:  Babak Jamali; Inga Bjørnsdottir; Ole Nordfang; Steen Honoré Hansen
Journal:  J Pharm Biomed Anal       Date:  2007-09-08       Impact factor: 3.935

Review 2.  Current challenges in non-invasive insulin delivery systems: a comparative review.

Authors:  El-Sayed Khafagy; Mariko Morishita; Yoshinori Onuki; Kozo Takayama
Journal:  Adv Drug Deliv Rev       Date:  2007-08-22       Impact factor: 15.470

Review 3.  Thiazolidinedione derivatives in diabetes and cardiovascular disease: an update.

Authors:  Pantelis A Sarafidis
Journal:  Fundam Clin Pharmacol       Date:  2008-04-15       Impact factor: 2.748

4.  Prevalence, treatment, and control of diagnosed diabetes in the U.S. National Health and Nutrition Examination Survey 1999-2004.

Authors:  Kwok Leung Ong; Bernard M Y Cheung; Louisa Y F Wong; Nelson M S Wat; Kathryn C B Tan; Karen S L Lam
Journal:  Ann Epidemiol       Date:  2008-01-16       Impact factor: 3.797

5.  Combretastatin A-4 activates AMP-activated protein kinase and improves glucose metabolism in db/db mice.

Authors:  Fang Zhang; Cheng Sun; Jingxia Wu; Chunyan He; Xinjian Ge; Wenming Huang; Yong Zou; Xingmiao Chen; Wei Qi; Qiwei Zhai
Journal:  Pharmacol Res       Date:  2008-03-15       Impact factor: 7.658

6.  The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes Prevention Study: a 20-year follow-up study.

Authors:  Guangwei Li; Ping Zhang; Jinping Wang; Edward W Gregg; Wenying Yang; Qiuhong Gong; Hui Li; Hongliang Li; Yayun Jiang; Yali An; Ying Shuai; Bo Zhang; Jingling Zhang; Theodore J Thompson; Robert B Gerzoff; Gojka Roglic; Yinghua Hu; Peter H Bennett
Journal:  Lancet       Date:  2008-05-24       Impact factor: 79.321

7.  Impact of the population at risk of diabetes on projections of diabetes burden in the United States: an epidemic on the way.

Authors:  A G Mainous; R Baker; R J Koopman; S Saxena; V A Diaz; C J Everett; A Majeed
Journal:  Diabetologia       Date:  2006-11-21       Impact factor: 10.122

8.  Colesevelam HCl improves glycemic control and reduces LDL cholesterol in patients with inadequately controlled type 2 diabetes on sulfonylurea-based therapy.

Authors:  Vivian A Fonseca; Julio Rosenstock; Antonia C Wang; Kenneth E Truitt; Michael R Jones
Journal:  Diabetes Care       Date:  2008-05-05       Impact factor: 19.112

9.  Prescription drug use and expenditures among dually eligible beneficiaries.

Authors:  Ann D Bagchi; Dominick Esposito; James M Verdier
Journal:  Health Care Financ Rev       Date:  2007
  9 in total
  1 in total

1.  The Impact of HbA1c Testing on Total Annual Healthcare Expenditures Among Newly Diagnosed Patients with Diabetes.

Authors:  Prajakta Bhounsule; Andrew M Peterson
Journal:  Am Health Drug Benefits       Date:  2015-09
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.